PURPLE BIOTECH LTD-ADR (PPBT) Stock Overview
NASDAQ:PPBT - US74638P1093 - ADR
PPBT Key Statistics, Chart & Performance
The current stock price of PPBT is 0.66 USD. In the past month the price decreased by -69.3%. In the past year, price decreased by -92.67%.
PPBT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 45.03 | 688.28B | ||
| JNJ | JOHNSON & JOHNSON | 17.84 | 429.72B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.4 | 253.31B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.66 | 251.14B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.13 | 245.41B | ||
| MRK | MERCK & CO. INC. | 11 | 211.59B | ||
| PFE | PFIZER INC | 7.34 | 141.46B | ||
| SNY | SANOFI-ADR | 10.47 | 113.41B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7 | 95.95B | ||
| GSK | GSK PLC-SPON ADR | 8.96 | 81.59B | ||
| ZTS | ZOETIS INC | 24.65 | 67.95B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 53.1 | 48.64B |
Related stock screener links
About PPBT
Company Profile
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Company Info
PURPLE BIOTECH LTD-ADR
4 Oppenheimer St., Science Park
Rehovot 7670104 IL
CEO: Gil Efron
Employees: 9
Phone: 97239333121
PURPLE BIOTECH LTD-ADR / PPBT FAQ
What is the stock price of PURPLE BIOTECH LTD-ADR today?
The current stock price of PPBT is 0.66 USD. The price decreased by -15.38% in the last trading session.
What is the ticker symbol for PURPLE BIOTECH LTD-ADR stock?
The exchange symbol of PURPLE BIOTECH LTD-ADR is PPBT and it is listed on the Nasdaq exchange.
On which exchange is PPBT stock listed?
PPBT stock is listed on the Nasdaq exchange.
What is PURPLE BIOTECH LTD-ADR worth?
PURPLE BIOTECH LTD-ADR (PPBT) has a market capitalization of 1.75M USD. This makes PPBT a Nano Cap stock.
How many employees does PURPLE BIOTECH LTD-ADR have?
PURPLE BIOTECH LTD-ADR (PPBT) currently has 9 employees.
Should I buy PURPLE BIOTECH LTD-ADR (PPBT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PPBT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PPBT, evaluating the profitability, health, valuation and growth aspects
- PURPLE BIOTECH LTD-ADR (PPBT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PURPLE BIOTECH LTD-ADR (PPBT) Sales and EPS estimates to see what analysts future expectations are.
- PURPLE BIOTECH LTD-ADR (PPBT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PURPLE BIOTECH LTD-ADR (PPBT) Insider and Institutional Ownership to learn about the owners and their transactions.
- PURPLE BIOTECH LTD-ADR (PPBT) Stock Chart to make your own analysis
- PURPLE BIOTECH LTD-ADR (PPBT) Latest news and press-releases to stay up to date.
Does PURPLE BIOTECH LTD-ADR (PPBT) stock pay dividends?
PPBT does not pay a dividend.
When does PURPLE BIOTECH LTD-ADR (PPBT) report earnings?
PURPLE BIOTECH LTD-ADR (PPBT) will report earnings on 2025-11-13.
What is the Price/Earnings (PE) ratio of PURPLE BIOTECH LTD-ADR (PPBT)?
PURPLE BIOTECH LTD-ADR (PPBT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.6).
What is the Short Interest ratio of PURPLE BIOTECH LTD-ADR (PPBT) stock?
The outstanding short interest for PURPLE BIOTECH LTD-ADR (PPBT) is 3.91% of its float. Check the ownership tab for more information on the PPBT short interest.
PPBT Technical Analysis
PPBT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PPBT. While PPBT seems to be doing ok healthwise, there are quite some concerns on its profitability.
PPBT Financial Highlights
Over the last trailing twelve months PPBT reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS increased by 94.2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.59% | ||
| ROE | -8.16% | ||
| Debt/Equity | 0 |